Categories: Wire Stories

Dr. Reddy’s Laboratories Announces the Launch of Treprostinil Injection in the U.S.

HYDERABAD, India–(BUSINESS WIRE)–$RDY #DRREDDY–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”), today announced the launch of Treprostinil Injection in the U.S. market, a therapeutic equivalent generic version of Remodulin� (treprostinil) Injection, approved by U. S. Food and Drug Administration (USFDA).

Dr. Reddy’s Treprostinil Injection is supplied as 20 mg/20 mL, 50 mg/20 mL, 100 mg/20 mL or 200 mg/20 mL vials.

Please click here to see the full prescribing information: https://www.drreddys.com/pi/150092607-Treprostinil-Injection-Leaflet.pdf

Remodulin® is a registered trademark of United Therapeutics Corporation.

RDY-0323-539

About Dr. Reddy’s: Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) is a global pharmaceutical company headquartered in Hyderabad, India. Established in 1984, we are committed to providing access to affordable and innovative medicines. Driven by our purpose of ‘Good Health Can’t Wait’, we offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Our major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Our major markets include – USA, India, Russia & CIS countries, China, Brazil and Europe. As a company with a history of deep science that has led to several industry firsts, we continue to plan ahead and invest in businesses of the future. As an early adopter of sustainability and ESG actions, we released our first Sustainability Report in 2004. Our current ESG goals aim to set the bar high in environmental stewardship; access and affordability for patients; diversity; and governance. For more information, log on to: www.drreddys.com.

Disclaimer: This press release may include statements of future expectations and other forward-looking statements that are based on the management’s current views and assumptions and involve known or unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. In addition to statements which are forward-looking by reason of context, the words “may”, “will”, “should”, “expects”, “plans”, “intends”, “anticipates”, “believes”, “estimates”, “predicts”, “potential”, or “continue” and similar expressions identify forward-looking statements. Actual results, performance or events may differ materially from those in such statements due to without limitation, (i) general economic conditions such as performance of financial markets, credit defaults , currency exchange rates, interest rates, persistency levels and frequency / severity of insured loss events, (ii) mortality and morbidity levels and trends, (iii) changing levels of competition and general competitive factors, (iv) changes in laws and regulations and in the policies of central banks and/or governments, (v) the impact of acquisitions or reorganization, including related integration issues, and (vi) the susceptibility of our industry and the markets addressed by our, and our customers’, products and services to economic downturns as a result of natural disasters, epidemics, pandemics or other widespread illness, including coronavirus (or COVID-19), and (vii) other risks and uncertainties identified in our public filings with the Securities and Exchange Commission, including those listed under the “Risk Factors” and “Forward-Looking Statements” sections of our Annual Report on Form 20-F for the year ended March 31, 2022. The company assumes no obligation to update any information contained herein.

Contacts

INVESTOR RELATIONS
RICHA PERIWAL

RICHAPERIWAL@DRREDDYS.COM

MEDIA RELATIONS
USHA IYER

USHAIYER@DRREDDYS.COM

Alex

Recent Posts

AIA Hong Kong continues to lead the insurance industry with 9 market No.1 in 2024

Number of New Business Policies tops the market for 11 consecutive years HONG KONG SAR…

19 hours ago

Feng Wei Ju and 8½ Otto e Mezzo BOMBANA Garner Coveted Diamond Awards in Black Pearl Restaurant Guide 2025

MACAU SAR - Media OutReach Newswire - 25 April 2025 - 2025 Black Pearl Restaurant…

19 hours ago

Creww and Real Madrid Next launch Batch 2 of “Real Madrid Next Accelerator for Asia”

TOKYO, JAPAN - Media OutReach Newswire - 25 April 2025 – Creww Inc. (Japan Office:…

20 hours ago

Digital Storytelling: “Zhengzhou in Cultural Relics” Debuts with AR Reconstructions Global Premiere on International Day for Monuments and Sites

ZHENGZHOU, CHINA - Media OutReach Newswire - 25 April 2025 – On International Day for…

20 hours ago

Chinese and foreign guests gather to talk about innovation and development of Museum in Liangzhu, Hangzhou

HANGZHOU, CHINA- Media OutReach Newswire - 25 April 2025 - From April 23 to 25,…

21 hours ago